Affärsvärlden gives a neutral recommendation for the medical technology company Synthetic MR in an analysis on Tuesday.The company has two really tough years behind it with declining sales and weak results. However, the acquisition of Finnish Combinostics has progressed well. Last fall, Lena Åredal took over as the new CEO.The stock has fallen by 70 percent over the past year and plunged 95 percent over the past three years. "The situation is uncertain, and we are watching developments from the sidelines with a neutral recommendation," writes Affärsvärlden.